Both rTMS and TDCS may be feasible and safe modalities for treating FM. The general effects of rTMS and TDCS are compatible in FM patients. M1 stimulation may be better in pain reduction and the dorsolateral prefrontal cortex may be better in depression improvement.

The results demonstrated that the ADL CAT is quick to administer, reliable, and valid in outpatients with stroke.

Understanding the predictive pathways of the integrated HL model could help clinicians to tailor HL interventions using a patient's personal determinants to facilitate participation in decision making and promote health for breast cancer patients.